JAMES COOPER to Chemical and Drug Induced Liver Injury
This is a "connection" page, showing publications JAMES COOPER has written about Chemical and Drug Induced Liver Injury.
Connection Strength
0.663
-
A Phase I dose-escalation study of DCLL9718S, an antibody-drug conjugate targeting C-type lectin-like molecule-1 (CLL-1) in patients with acute myeloid leukemia. Am J Hematol. 2021 05 01; 96(5):E175-E179.
Score: 0.663